I97.2 vs T80.82XD
I97.2 (Postmastectomy lymphedema syndrome) compared with T80.82XD (Complication of immune effector cellular therapy, subsequent encounter), from the official CMS tabular data. Both may be reported when both conditions are documented (Excludes2).
Can these codes be reported together?
Yes, when both are documented. T80.82XD carries an Excludes2 note covering I97.2: “postmastectomy lymphedema syndrome (I97.2)”
Excludes2 marks distinct conditions — both may be reported when both are documented.
Side by side
| I97.2Postmastectomy lymphedema syndrome | T80.82XDComplication of immune effector cellular therapy, subsequent encounter | |
|---|---|---|
| Billing status | Billable | Billable |
| Classification | I00-I99 — Diseases of the Circulatory System (I00-I99) | S00-T88 — Injury, Poisoning and Certain Other Consequences of External Causes (S00-T88) |
| Definition | Postmastectomy lymphedema syndrome is a billable ICD-10-CM diagnosis code (I97.2). | Complication of immune effector cellular therapy, subsequent encounter is a billable ICD-10-CM diagnosis code (T80.82D). |
| 7th character | — | The appropriate 7th character is to be added to each code from category T80 |
| Includes | Elephantiasis due to mastectomy Obliteration of lymphatic vessels | complications following perfusion Complication of chimeric antigen receptor (CAR-T) cell therapy Complication of IEC therapy |
| Use additional code | — | code to identify the specific complication, such as: cytokine release syndrome (D89.83-) immune effector cell-associated neurotoxicity syndrome (G92.0-) |
Derived from the official CMS ICD-10-CM tabular data (FY2026). Not billing advice; verify sequencing rules for the encounter. All data sources